MCLEAN, Va., Nov. 14, 2017 — airPHX (“air fix”) announces independent research confirming the effectiveness of airPHX technology in eliminating three common healthcare-associated infection (HAI) pathogens. The research, conducted by Rick Falkenberg, Ph.D with Scientific Air Solutions and published September 13, 2017, demonstrates over 4-log reductions in 30 minutes of treatment in bacterial populations of Clostridium difficile, Methicillin Resistant Staphylococcus aureus (mRSA) and Pseudomonas aeruginosa on three common contact surfaces: stainless steel, plastic (PVC) and linoleum (floor tile). Each bacterial population exhibited in excess of 5-log reductions in organisms in 2 hours of treatment. The research can be reviewed at https://www.airPHXhealth.com/blog
Antimicrobial resistant pathogens pose an ongoing challenge to hospitals because they cause HAIs during clinical treatment of patients. Existing methods to address this challenge include sanitizers/disinfectants and deployment of UV-C technology. Both solutions have limitations and neither solution provides ongoing protection between treatments.
airPHX technology operates continuously in the background as a prophylaxis with no labor costs and minimal operating expenses. airPHX uses a proprietary atmospheric cold plasma technology to create and distribute a low-level, unique spectrum of reactive oxygen species (ROS). The ROS operate as an oxidizer of pathogens in a treatment space, persistently eliminating airborne and surface pathogens in the air and on all surfaces exposed to ambient air.
According to Dr. Falkenberg: “the technology developed by airPHX has a wide range of applications due to its ability to produce a highly oxidative environment within a reaction chamber and discharge molecules that have an oxidizing capacity at levels that are safe for human exposure into the environment.”
airPHX technology has previously been commercialized for large facilities in food safety applications. Adapting the technology for the health care industry was a natural progression. Deployed in hospitals, medical device storage, senior care, athletic facilities and other health facilities, airPHX technology provides immediate and continuing infection control at low capital and operating costs.
For complete information on the airPHX system and research results, please visit: www.airPHXhealth.com.
About airPHX | HEALTH
airPHX is a private company offering air and surface sanitization solutions. It is known for its cost-effective and innovative technology that delivers results without the usage of chemicals or UV radiation.
View original content with multimedia:http://www.prnewswire.com/news-releases/airphx-validates-technology-for-eliminating-pathogens-on-surfaces-in-health-care-facilities-300555785.html
Latest posts by Brad Bennett (see all)
- MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, California - February 18, 2018
- Mario Lopez Announced As Host To The 'Splash of Love' Gala Fundraiser At Proud Bird Food Bazaar & Events Center - February 18, 2018
- Oxnard Teen, Skilled Boxer Honored as BGCOP's Youth of the Year - February 18, 2018